JUSTIN MIKESELL: Open Payments
NPI 1649991720 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 41 payments from 16 companies in 2025. Trend: 2023 $1,561 · 2024 $1,237 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 7 | $162 |
| GENZYME CORPORATION | 3 | $140 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| ABBVIE INC. | 4 | $79 |
| Incyte Corporation | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Lilly USA, LLC | 3 | $57 |
| PFIZER INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 3 | $53 |
| Organon LLC | 2 | $49 |
Products named: DUPIXENT, Zoryve, SKYRIZI, OPZELURA, TALTZ, CIBINQO, NEMLUVIO, TREMFYA.
Industry payments across CA — which companies pay providers there.
